Alteplase Injection — FDA Drug Shortage

To Be Discontinued — Genentech, Inc

The FDA lists a drug shortage record for Alteplase Injection (injection) from Genentech, Inc with status To Be Discontinued. The shortage was first posted on May 21, 2026.

Shortage details

Status
To Be Discontinued
Company
Genentech, Inc
Package NDC
50242-085-27
Dosage Form
Injection
Presentation
Activase, Injection, 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE USE (NDC 50242-085-27)
Initial Posting
May 21, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.